130 related articles for article (PubMed ID: 2565975)
21. Influence of dietary supplementation with olive oil on pyroglutamyl-beta-naphthylamide hydrolysing activity in serum and different tissues of mice.
Martínez JM; Ramírez MJ; Prieto I; Alba F; Ramírez M
Folia Biol (Praha); 1998; 44(6):213-6. PubMed ID: 10730865
[TBL] [Abstract][Full Text] [Related]
22. Occurrence of the free and Peptide forms of pyroglutamic acid in plasma from the portal blood of rats that had ingested a wheat gluten hydrolysate containing pyroglutamyl peptides.
Higaki-Sato N; Sato K; Inoue N; Nawa Y; Kido Y; Nakabou Y; Hashimoto K; Nakamura Y; Ohtsuki K
J Agric Food Chem; 2006 Sep; 54(19):6984-8. PubMed ID: 16968052
[TBL] [Abstract][Full Text] [Related]
23. O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides.
Sohma Y; Hayashi Y; Skwarczynski M; Hamada Y; Sasaki M; Kimura T; Kiso Y
Biopolymers; 2004; 76(4):344-56. PubMed ID: 15386265
[TBL] [Abstract][Full Text] [Related]
24. Isolation and identification of indigestible pyroglutamyl peptides in an enzymatic hydrolysate of wheat gluten prepared on an industrial scale.
Higaki-Sato N; Sato K; Esumi Y; Okumura T; Yoshikawa H; Tanaka-Kuwajima C; Kurata A; Kotaru M; Kawabata M; Nakamura Y; Ohtsuki K
J Agric Food Chem; 2003 Jan; 51(1):8-13. PubMed ID: 12502378
[TBL] [Abstract][Full Text] [Related]
25. A technique for the removal of pyroglutamic acid from the amino terminus of proteins using calf liver pyroglutamate amino peptidase.
Podell DN; Abraham GN
Biochem Biophys Res Commun; 1978 Mar; 81(1):176-85. PubMed ID: 26343
[No Abstract] [Full Text] [Related]
26. Homology modeling and site-directed mutagenesis of pyroglutamyl peptidase II. Insights into omega-versus aminopeptidase specificity in the M1 family.
Chávez-Gutiérrez L; Matta-Camacho E; Osuna J; Horjales E; Joseph-Bravo P; Maigret B; Charli JL
J Biol Chem; 2006 Jul; 281(27):18581-90. PubMed ID: 16611635
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of some substrates and potential inhibitors of tissue pyroglutamyl aminopeptidase I.
Svoboda KS; Currie BL
Neuropeptides; 1992 Feb; 21(2):85-92. PubMed ID: 1348354
[TBL] [Abstract][Full Text] [Related]
28. Pyroglutamyl N-termini of thermal polyamino acids.
Melius P; Hubbard WL
Biosystems; 1987; 20(3):213-7. PubMed ID: 2887217
[TBL] [Abstract][Full Text] [Related]
29. Degradation of pyroglutamyl-phenylalanyl-proline amide by a pyroglutamyl aminopeptidase purified from membrane fractions of bovine brain.
Kelly JA; Loscher CE; Gallagher S; O'Connor B
Biochem Soc Trans; 1997 Feb; 25(1):114S. PubMed ID: 9057012
[No Abstract] [Full Text] [Related]
30. Demonstration of a pyroglutamyl residue at the N terminus of the B-chain of porcine relaxin.
Schwabe C; McDonald JK
Biochem Biophys Res Commun; 1977 Feb; 74(4):1501-4. PubMed ID: 843375
[No Abstract] [Full Text] [Related]
31. Assay of pyroglutamyl aminopeptidase by high-performance liquid chromatography and its use in peptide sequencing.
Martini F; Bossa F; Barra D
Peptides; 1985; 6 Suppl 3():103-5. PubMed ID: 2870471
[TBL] [Abstract][Full Text] [Related]
32. Pyroglutamyl peptidase: an overview of the three known enzymatic forms.
Cummins PM; O'Connor B
Biochim Biophys Acta; 1998 Dec; 1429(1):1-17. PubMed ID: 9920379
[TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of pyroglutamic acid in peptides.
Suzuki Y; Motoi H; Sato K
J Agric Food Chem; 1999 Aug; 47(8):3248-51. PubMed ID: 10552639
[TBL] [Abstract][Full Text] [Related]
34. Prodrugs of peptides. 11. Chemical and enzymatic hydrolysis kinetics of N-acyloxymethyl derivatives of a peptide-like bond.
Bundgaard H; Rasmussen GJ
Pharm Res; 1991 Oct; 8(10):1238-42. PubMed ID: 1796040
[TBL] [Abstract][Full Text] [Related]
35. New chromogenic and fluorogenic substrates for pyrrolidonyl peptidase.
Fujiwara K; Tsuru D
J Biochem; 1978 Apr; 83(4):1145-9. PubMed ID: 26673
[TBL] [Abstract][Full Text] [Related]
36. The development of two fluorimetric assays for the determination of pyroglutamyl aminopeptidase type-II activity.
Gallagher SP; O'Leary RM; O'Connor B
Anal Biochem; 1997 Jul; 250(1):1-9. PubMed ID: 9234892
[TBL] [Abstract][Full Text] [Related]
37. Prodrugs as drug delivery systems IV: N-Mannich bases as potential novel prodrugs for amides, ureides, amines, and other NH-acidic compounds.
Bundgaard H; Johansen M
J Pharm Sci; 1980 Jan; 69(1):44-6. PubMed ID: 7354439
[TBL] [Abstract][Full Text] [Related]
38. pGlu-L-Dopa-Pro: a tripeptide prodrug targeting the intestinal peptide transporter for absorption and tissue enzymes for conversion.
Bai JP
Pharm Res; 1995 Jul; 12(7):1101-4. PubMed ID: 7494810
[TBL] [Abstract][Full Text] [Related]
39. The use of FAB mass spectrometry and pyroglutamate aminopeptidase digestion for the structure determination of pyroglutamate in modified peptides.
Kim J; Kim K
Biochem Mol Biol Int; 1995 Apr; 35(4):803-11. PubMed ID: 7627130
[TBL] [Abstract][Full Text] [Related]
40. Studies of substrate requirements, kinetic properties, and competive inhibitors of the enzymes catabolizing TRH in rat brain.
Busby WH; Youngblood WW; Kizer JS
Brain Res; 1982 Jun; 242(2):261-70. PubMed ID: 6126250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]